Johnson & Johnson’s Q1 Checkup: Mixed Results, Optimism Remains
Medicines Co.
WKN: 938858 / Symbol: MDCO / Name: Medicines / Aktie / Pharmazeutika / Mid Cap /
76,00 €
-
![Johnson & Johnson’s Q1 Checkup: Mixed Results, Optimism Remains: https://www.marketbeat.com/logos/articles/med_20240416234302_johnson-johnsons-q1-checkup-mixed-results-optimism.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBNTUzYkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--0687dee529cd90eca6499e8d6975cf7f3284c512/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20240416234302_johnson-johnsons-q1-checkup-mixed-results-optimism.jpg?locale=de)
Johnson & Johnson’s Q1 Checkup: Mixed Results, Optimism Remains
Johnson & Johnson (NYSE: JNJ) is one of the world's largest healthcare companies, with a diverse product portfolio that includes pharmaceuticals, medical devices and consumer health products
Der Beitrag wird untersucht
Neueste Beiträge
kneepadsbrush in EQS-Adhoc: Siemens Energy AG: Siemens Energy comments on media reports